Prognostic value of 18F-FDG PET/CT metabolic parameters in small cell lung cancer
- PMID: 31880209
- PMCID: PMC7607737
- DOI: 10.1177/0300060519892419
Prognostic value of 18F-FDG PET/CT metabolic parameters in small cell lung cancer
Abstract
Objective: To compare the prognostic values of metabolic parameters from pretreatment PET/CT between limited disease (LD) and extensive disease (ED) small cell lung cancer (SCLC) patients.
Methods: Data on 118 newly diagnosed SCLC patients (50 LD and 68 ED) who underwent pretreatment positron emission tomography-computed tomography (PET/CT) were reviewed. For PET, metabolic parameters were measured for: (1) primary tumor, maximum standardized uptake value (SUVmax), metabolic tumor volume, and total lesion glycolysis; and (2) all tumor lesions, SUVmax of the hottest tumor, whole body metabolic tumor volume (WBMTV), and whole body total lesion glycolysis (WBTLG). Prognostic values of metabolic parameters and other clinical variables were analyzed to predict overall survival (OS).
Results: In LD, SUVmax of the primary tumor was an independent prognostic factor for OS. Patients with high SUVmax showed significantly worse OS than those with low SUVmax. In ED, WBMTV and WBTLG were independent prognostic factors for OS. Patients with high WBMTV or WBTLG showed significantly worse OS than those with low WBMTV or WBTLG.
Conclusions: SUVmax of primary tumor was the only independent prognostic factor for OS in LD SCLC patients. WBMTV and WBTLG were independent prognostic factors in ED SCLC patients.
Keywords: Small cell lung carcinoma; extensive disease; fluorodeoxyglucose F18; limited disease; positron emission tomography–computed tomography; prognosis.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
Similar articles
-
Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC).Int J Clin Oncol. 2019 Feb;24(2):168-178. doi: 10.1007/s10147-018-1338-8. Epub 2018 Aug 14. Int J Clin Oncol. 2019. PMID: 30109543
-
[Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer].Zhonghua Zhong Liu Za Zhi. 2017 Nov 23;39(11):828-834. doi: 10.3760/cma.j.issn.0253-3766.2017.11.005. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 29151289 Chinese.
-
Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1321-9. doi: 10.1007/s00259-013-2443-6. Epub 2013 May 15. Eur J Nucl Med Mol Imaging. 2013. PMID: 23674211
-
Prognostic value of metabolic tumour volume and total lesion glycolysis measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in small cell lung cancer: A systematic review and meta-analysis.J Med Imaging Radiat Oncol. 2019 Feb;63(1):84-93. doi: 10.1111/1754-9485.12805. Epub 2018 Sep 19. J Med Imaging Radiat Oncol. 2019. PMID: 30230710
-
Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.PLoS One. 2016 Jan 4;11(1):e0146195. doi: 10.1371/journal.pone.0146195. eCollection 2016. PLoS One. 2016. PMID: 26727114 Free PMC article. Review.
Cited by
-
Primary tumor SUVmax and ratio of SUVmax to primary tumor size on pretreatment 18F-FDG-PET/CT scan in small cell lung cancer : Which is superior for the prognosis?Wien Klin Wochenschr. 2023 Sep;135(17-18):478-487. doi: 10.1007/s00508-023-02160-0. Epub 2023 Mar 7. Wien Klin Wochenschr. 2023. PMID: 36882606
-
Association between PET-CT accumulation in the hypothalamic/pituitary regions and neuron-specific enolase/primary tumor in limited-stage small cell lung cancer: a case-controlled retrospective study.EJNMMI Rep. 2024 Feb 5;8(1):4. doi: 10.1186/s41824-024-00190-z. EJNMMI Rep. 2024. PMID: 38748049 Free PMC article.
-
Prognostic Value of 18F-FDG-PET Parameters in Patients with Small Cell Lung Cancer: A Meta-Analysis and Review of Current Literature.Diagnostics (Basel). 2021 Jan 26;11(2):174. doi: 10.3390/diagnostics11020174. Diagnostics (Basel). 2021. PMID: 33530446 Free PMC article. Review.
-
Clinical imaging of primary pulmonary nucleoprotein of the testis carcinoma.Front Med (Lausanne). 2023 Jan 4;9:1083206. doi: 10.3389/fmed.2022.1083206. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36687409 Free PMC article.
-
Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival.Theranostics. 2024 Aug 26;14(14):5400-5412. doi: 10.7150/thno.98819. eCollection 2024. Theranostics. 2024. PMID: 39310095 Free PMC article.
References
-
- van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet 2011; 378: 1741–1755. - PubMed
-
- Morabito A, Carillio G, Daniele G, et al. Treatment of small cell lung cancer. Crit Rev Oncol Hematol 2014; 91: 257–270. - PubMed
-
- Zhang X, Guo M, Fan J, et al. Prognostic significance of serum LDH in small cell lung cancer: a systematic review with meta-analysis. Cancer Biomark 2016; 16: 415–423. - PubMed
-
- Ando S, Suzuki M, Yamamoto N, et al. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer. Anticancer Res 2004; 24: 1941–1946. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials